Commonly searched applications: mitochondrial research, energy research.
Price comparison
Compare Elamipretide providers
Select a dose to see the cheapest documented option that covers it. Providers with verified same-price-across-dose terms are included automatically at every applicable dose; there is no separate flat-price selection. Flat-rate and variable dose-tier providers compete together, with verified required fees included. Comparable monthly, 28-day, 30-day, and four-week injection supplies retain their actual billing labels; no monthly equivalent is invented. Unmatched offers remain visible but unranked. Dose tiers are catalog information, not dosing advice.
SS-31 (50 mg) (3ml) - Lyophilized — Sold out when checked · $299 per program package · Lyophilized SS-31 50 mg in 3 mL; current direct page is unavailable for purchase.Headline price source
Subcutaneous SS-31 + NAD+ blend; provider lists 25 IU for men or 20 IU for women, Monday-Friday mornings, for five or ten weeks.; 5-week program; 10-week program
Current Recess Rx managed-medication identity; exact route, strength, concentration, package, prescribed duration, pharmacy, and medication amount are not public.
SS-31 (50 mg) (3ml) - Lyophilized — Sold out when checked · $299 per program package · Lyophilized SS-31 50 mg in 3 mL; current direct page is unavailable for purchase.Headline price source
Subcutaneous SS-31 + NAD+ blend; provider lists 25 IU for men or 20 IU for women, Monday-Friday mornings, for five or ten weeks.; 5-week program; 10-week program
Current Recess Rx managed-medication identity; exact route, strength, concentration, package, prescribed duration, pharmacy, and medication amount are not public.
Subcutaneous Elamipretide/SS-31, 0. 2 mL once daily at bedtime; concentration is not public.
Video or phone visit
Regulatory context under reviewSources checked Aug 16, 2026
Regulatory and pricing context
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion. Context source
Displayed prices and dose options are provider-stated snapshots. They may vary by dose, formulation, shipping, state, eligibility, insurance, commitment length, and required subscription. “Not listed” means the reviewed public source did not provide a value.
Information only; not medical advice, a safety evaluation, or a provider endorsement.
Research-use-only suppliers are separate. Their catalog prices never enter the prescription-provider comparison above.